Akari Therapeutics Plc ADR

Analysts Viewpoint

Negative sentiment towards AKTX reflected by a jump of 77.06% in short interest

Daniel Torres

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Stock Earnings

A Guide To The Risks Of Investing In Akari Therapeutics Plc ADR (AKTX)

Jaxson Clark

Akari Therapeutics Plc ADR’s filing revealed that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug 21 ...

Insiders Updates

Investing in Akari Therapeutics Plc ADR (AKTX): What You Must Know

Daniel Torres

Akari Therapeutics Plc ADR’s recent filing unveils that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug ...

Insiders Updates

Akari Therapeutics Plc ADR (AKTX) receives a Buy rating from Maxim Group

Jaxson Clark

Akari Therapeutics Plc ADR’s recent filing unveils that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.